Retrospective Analysis of Treatment-naive Slovenian Patients with Metastatic Melanoma Treated with Pembrolizumab – Real-world Experience

BACKGROUND: Based on recent data from clinical trials, the immune checkpoint inhibitor pembrolizumab prolongs survival and has a good toxicity profile in patients with advanced or metastatic melanoma. However, the question remains whether these results are transmitted into daily clinical practice. T...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Radiol Oncol
Main Authors: Hribernik, Nezka, Boc, Marko, Ocvirk, Janja, Knez-Arbeiter, Jasna, Mesti, Tanja, Ignjatovic, Marija, Rebersek, Martina
Formato: Artigo
Idioma:Inglês
Publicado: Sciendo 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087416/
https://ncbi.nlm.nih.gov/pubmed/31955148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2020-0003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares